Tech & Pharma
CEL-SCI has begun enrolling patients from Sri Lanka for a Phase III trial for Multikine, an investigational treatment for head and neck cancer.
Tata Communication’s US$200 million investment will double the capacity of its data center in New Delhi.
The two-sided, transparent TransWall developed at KAIST provides users with interactive haptic feedback.
Launching satellites for countries including Japan and Singapore has earned the Indian Space Research Organization US$54 million in the last three years.
Luye Pharma has raised US$764 million through an IPO on the Main Board of the Stock Exchange of Hong Kong.
In a reversal of a previous ruling banning clinical genetic testing, the CFDA has approved BGI’s prenatal testing kits.
A portable antibiotic tester invented at BITS Pilani, Hyderabad will be commercially developed by a university spin-off company xBITS.
Designed and built by students and researchers at NTU, the satellites VELOX-I and VELOX-PIII are now orbiting 650 km above the Earth.
BeiGene’s PARP inhibitor BGB-290 could be an important treatment for common cancers such as gastric cancer and primary brain tumors.
The partnership between Sanofi and Takeda aims to raise diabetes awareness and provide educational support for both patients and healthcare professionals.